|
OXA1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.870600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.742800E-01 |
| Normal-vs-Stage2 |
2.223900E-02 |
| Normal-vs-Stage3 |
8.787200E-01 |
| Normal-vs-Stage4 |
7.373200E-01 |
| Stage1-vs-Stage2 |
9.581600E-03 |
| Stage1-vs-Stage3 |
8.744200E-01 |
| Stage1-vs-Stage4 |
7.121600E-01 |
| Stage2-vs-Stage3 |
1.371610E-02 |
| Stage2-vs-Stage4 |
1.285910E-02 |
| Stage3-vs-Stage4 |
8.580400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.610800E-01 |
| Normal-vs-AfricanAmerican |
8.207400E-01 |
| Normal-vs-Asian |
1.618390E-01 |
| Caucasian-vs-AfricanAmerican |
7.303200E-01 |
| Caucasian-vs-Asian |
8.678500E-02 |
| AfricanAmerican-vs-Asian |
3.796400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.528400E-01 |
| Normal-vs-Female |
9.907200E-01 |
| Male-vs-Female |
1.550420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.454000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.243800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.174500E-02 |
| Normal-vs-Age(81-100Yrs) |
8.143800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.312400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.289600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.205690E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.389600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.982700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.15780000000421E-05 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.156000E-01 |
| Classical-VS-Follicular |
2.099400E-01 |
| Classical-VS-Other |
5.538600E-01 |
| Classical-VS-Normal |
8.104600E-01 |
| Tall-VS-Follicular |
3.307400E-01 |
| Tall-VS-Other |
5.790000E-01 |
| Tall-VS-Normal |
9.401600E-01 |
| Follicular-VS-Other |
9.776000E-01 |
| Follicular-VS-Normal |
2.322400E-01 |
| Other-VS-Normal |
5.144000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.837200E-01 |
| Normal-vs-N1 |
1.807210E-01 |
| N0-vs-N1 |
5.395500E-02 |
|
|
